Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057001 · ClinicalTrials.gov registry record
Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 49
- Enrollment target
NCT04057001 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 49 participants.
The verdict
NCT04057001 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 49 participants
- Enrollment target
Study Summary
Compare wait list mortality and time to liver, heart or kidney transplant for registrants listed to consider allografts from Hepatitis C Virus (HCV) Nucleic Amplification Testing (NAT)+ donors versus those who are not . The umbrella protocol has been set up to include heart and kidney transplant recipients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2023-03-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04057001
The ClinicalTrials.gov registry entry for NCT04057001 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04057001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04057001 about?
NCT04057001 is a clinical study titled "Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study". Compare wait list mortality and time to liver, heart or kidney transplant for registrants listed to consider allografts from Hepatitis C Virus (HCV) Nucleic Amplification Testing (NAT)+ donors versus those who are not . The umbrella protocol has been set up to include heart and kidney transplant rec...
What is the current status of trial NCT04057001?
This trial is currently terminated. The enrollment target is 49 participants. The study started on 2019-07-01. Estimated completion is 2023-03-06.
Who is sponsoring clinical trial NCT04057001?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.